These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32576928)

  • 1. DREAM-in-CDM Approach and Identification of a New Generation of Anti-inflammatory Drugs Targeting mPGES-1.
    Zhou S; Zhou Z; Ding K; Yuan Y; Loftin C; Zheng F; Zhan CG
    Sci Rep; 2020 Jun; 10(1):10187. PubMed ID: 32576928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical data mining reveals analgesic effects of lapatinib in cancer patients.
    Zhou S; Zheng F; Zhan CG
    Sci Rep; 2021 Feb; 11(1):3528. PubMed ID: 33574423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsomal prostaglandin E
    Zhang YY; Yao YD; Luo JF; Liu ZQ; Huang YM; Wu FC; Sun QH; Liu JX; Zhou H
    Pharmacol Res; 2022 Jan; 175():105977. PubMed ID: 34798265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19.
    Husain A; Byrareddy SN
    Chem Biol Interact; 2020 Nov; 331():109282. PubMed ID: 33031791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data.
    Chakraborti S; Bheemireddy S; Srinivasan N
    Mol Omics; 2020 Oct; 16(5):474-491. PubMed ID: 32696772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsomal prostaglandin E
    Psarra A; Nikolaou A; Kokotou MG; Limnios D; Kokotos G
    Expert Opin Ther Pat; 2017 Sep; 27(9):1047-1059. PubMed ID: 28627961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
    Costiniuk CT; Jenabian MA
    Cytokine Growth Factor Rev; 2020 Jun; 53():63-65. PubMed ID: 32467020
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of microsomal PGE synthase-1 reduces human vascular tone by increasing PGI
    Ozen G; Gomez I; Daci A; Deschildre C; Boubaya L; Teskin O; Uydeş-Doğan BS; Jakobsson PJ; Longrois D; Topal G; Norel X
    Br J Pharmacol; 2017 Nov; 174(22):4087-4098. PubMed ID: 28675448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19.
    Saul S; Einav S
    ACS Infect Dis; 2020 Sep; 6(9):2304-2318. PubMed ID: 32687696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based discovery of mPGES-1 inhibitors suitable for preclinical testing in wild-type mice as a new generation of anti-inflammatory drugs.
    Ding K; Zhou Z; Hou S; Yuan Y; Zhou S; Zheng X; Chen J; Loftin C; Zheng F; Zhan CG
    Sci Rep; 2018 Mar; 8(1):5205. PubMed ID: 29581541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of microsomal prostaglandin E-synthase-1 (mPGES-1) selectively suppresses PGE
    Martin EM; Jones SL
    Vet Immunol Immunopathol; 2017 Oct; 192():33-40. PubMed ID: 29042013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing old drugs as antiviral agents for coronaviruses.
    Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
    Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods.
    Unni S; Aouti S; Thiyagarajan S; Padmanabhan B
    J Biosci; 2020; 45(1):. PubMed ID: 33184246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design.
    Meyer-Almes FJ
    Comput Biol Chem; 2020 Oct; 88():107351. PubMed ID: 32769050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Development of Microsomal Prostaglandin E2 Synthase-1 Inhibitors: Challenges and Future Directions.
    Koeberle A; Laufer SA; Werz O
    J Med Chem; 2016 Jul; 59(13):5970-86. PubMed ID: 26791385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibitors of human mPGES-1 from structure-based computational screening.
    Zhou Z; Yuan Y; Zhou S; Ding K; Zheng F; Zhan CG
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3739-3743. PubMed ID: 28689972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence approach fighting COVID-19 with repurposing drugs.
    Ke YY; Peng TT; Yeh TK; Huang WZ; Chang SE; Wu SH; Hung HC; Hsu TA; Lee SJ; Song JS; Lin WH; Chiang TJ; Lin JH; Sytwu HK; Chen CT
    Biomed J; 2020 Aug; 43(4):355-362. PubMed ID: 32426387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ellagitannins from
    Toda K; Ueyama M; Tanaka S; Tsukayama I; Mega T; Konoike Y; Tamenobu A; Bastian F; Akai I; Ito H; Kawakami Y; Takahashi Y; Suzuki-Yamamoto T
    Biosci Biotechnol Biochem; 2020 Apr; 84(4):757-763. PubMed ID: 31868102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung.
    Dastan F; Abedini A; Shahabi S; Kiani A; Saffaei A; Zare A
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):10-12. PubMed ID: 32534505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.